TGFB1 and arthritic joint disease: Hence, the degree of arthritis in the sCD83/TGF-β treated group was between the one of sCD83 treatment and mock treated mice, indicating that TGF-β plays a role but is not exclusively responsible for sCD83 mediated anti-arthritic effects.